Literature DB >> 34410472

Endolymphatic sac tumor: single-institution series of seven cases with updated review of literature.

Riddhijyoti Talukdar1, Sridhar Epari2, Ayushi Sahay2, Amit Choudhari3, Archya Dasgupta1, Abhishek Chatterjee1, Tejpal Gupta4.   

Abstract

BACKGROUND: Endolymphatic sac tumour (ELST) is a rare low-grade locally aggressive neoplasm arising from the endolymphatic duct or sac. It presents mostly with vestibulo-cochlear symptoms either sporadically or as part of von Hippel-Lindau (VHL) syndrome. Micro-neurosurgical excision remains the cornerstone of therapy with the role of radiotherapy (RT) being controversial. This is a clinico-pathological analysis of consecutive ELST patients presenting to a single-institution in India.
METHODS: Neuropathology database of a tertiary-care comprehensive cancer centre was searched electronically to identify consecutive patients with histopathological diagnosis of ELST registered at the institute over last one decade. Data regarding demographic profile, clinical presentation, histopathological features, treatment details and outcomes were retrieved from electronic medical records for this retrospective analysis.
RESULTS: Electronic search identified seven unique patients with biopsy-proven ELST registered at the institute between 2009 and 2020. Median age of the study cohort was 39 years (range 24-65 years) with strong male predilection (5:2 ratio) and left-sided preponderance (71%). Most common presenting symptoms were hearing loss (86%) and earache (71%) on affected side followed by headache (43%). All patients underwent maximal safe resection at initial diagnosis and were followed-up closely with periodic surveillance imaging. Two patients underwent salvage RT using high-precision conformal techniques at recurrence/progression.
CONCLUSION: ELST is a rare low-grade locally aggressive neoplasm that arises generally as part of VHL syndrome or sometimes sporadically. Gross total resection provides the best chance of cure with RT being reserved for unresectable disease, large residue, medical inoperability, or as salvage therapy for recurrent/progressive tumor.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Endolymphatic sac tumor; Familial; Histopathology; Management; Sporadic

Mesh:

Year:  2021        PMID: 34410472     DOI: 10.1007/s00405-021-07047-2

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  6 in total

1.  Spinal metastasis from endolymphatic sac tumor.

Authors:  K Y Tay; E Yu; E Kassel
Journal:  AJNR Am J Neuroradiol       Date:  2007-04       Impact factor: 3.825

2.  Management of squamous cell carcinoma of the temporal bone: long-term results and factors influencing outcomes.

Authors:  Gianluca Piras; Golda Grinblat; Riccardo Albertini; Vittoria Sykopetrites; Shi-Xun Zhong; Lorenzo Lauda; Mario Sanna
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-09-26       Impact factor: 2.503

3.  Adenoma of the endolymphatic sac.

Authors:  A D Hassard; S F Boudreau; C C Cron
Journal:  J Otolaryngol       Date:  1984-08

4.  Development and validation of a novel metabolic signature for predicting prognosis in patients with laryngeal cancer.

Authors:  Wenfei Li; Min Fu; Kun Zhao; Fang Han; Ning Bu; Zhanqiu Wang
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-10-27       Impact factor: 2.503

5.  Papillary-cystic neoplasms of the middle ear are distinct from endolymphatic sac tumours.

Authors:  Cecilia Taverna; Federica Pollastri; Rudi Pecci; Beatrice Giannoni; Caterina Fattorini; Marco Santucci; Sarina K Mueller; Robert Stoehr; Alessandro Franchi; Abbas Agaimy
Journal:  Histopathology       Date:  2020-11-09       Impact factor: 5.087

6.  A rare case of endolymphatic sac tumour: clinicopathologic study and surgical management.

Authors:  Emanuele Ferri; Maurizio Amadori; Enrico Armato; Ida Pavon
Journal:  Case Rep Otolaryngol       Date:  2014-06-04
  6 in total
  1 in total

1.  Endolymphatic sac tumor in an 8-month-old cat.

Authors:  Matteo Baccolini; Marco Rosati; Federica Tirrito; Francesca Cozzi; Rocco Lombardo
Journal:  Open Vet J       Date:  2022-05-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.